Johnson & Johnson has announced that its Board of Directors has declared a cash dividend for the third quarter of 2025 of $1.30 per share on the company’s common stock. The dividend is payable on September 9, 2025 to shareholders of record at the close of business on August 26, 2025. The ex-dividend date is August 26, 2025.
Source: Johnson & Johnson
Penumbra, Inc. has announced it has received U.S. Food and Drug Administration (FDA) clearance for THUNDERBOLT™, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke...
Expanded U.S. availability paired with new patient lifestyle quiz encourages informed decision-making ahead of cataract surgery. Cataracts are one of the leading causes of vision impairment.1 Nearly 20% of Americans...
KARL STORZ has received FDA clearance for the Rubina™ Lens exoscope for open surgery, broadening the company’s near-infrared (NIR) imaging ecosystem across open and minimally invasive procedures in the United States...
Surgical Robotics Technology provides the latest news, events, products, technology and jobs from the Surgical Robotics industry.
© 2026. Surgical Robotics Technology. Part of the Technology Online Group. Company No. 13329353
Surgical Robotics Technology
